GOSS Gossamer Bio Inc
Company Analysis
Latest News
🔴 Gossamer Bio is trading 5.4% down — no clear company announcement explains the drop
Gossamer Bio is trading at $10.13, down 5.37%, with no reported company announcement explaining the October 5 decline. - An October 1 report noted divided...
🔴 Gossamer Bio is trading 7.1% down with no clear catalyst identified
Gossamer Bio is trading at $11.01, down 7.09%, with no clear company-specific catalyst identified for the decline. - The September 23 seralutinib FDA...
🟢 Gossamer Bio is trading 5.7% up — no clear company-specific catalyst identified
Gossamer Bio is trading at $12.24, up +5.70%, with no clear company-specific catalyst identified for the move. - No clear company-specific announcement or...
GOSS Regains Nasdaq Listing Compliance Following 1-for-80 Reverse Stock Split
Gossamer Bio, Inc. announced it has regained compliance with the Nasdaq's minimum bid price requirement, resolving a potential delisting issue. The company...
🟢 Gossamer Bio is trading 6.86% up with no clear company-specific catalyst
Gossamer Bio is trading 6.86% higher at $11.69 on September 28, 2026, with no clear company-specific announcement identified to explain the gain. - Its latest...
🔴 Gossamer Bio is trading 5.3% down in after-hours trading as PROSERA missed its prespecified statistical threshold
Gossamer Bio is trading 5.3% down at $10.36 after-hours as investors reassess seralutinib after the PROSERA trial missed its prespecified statistical...
🔴 Gossamer Bio is trading 5.5% down today as FDA has yet to accept seralutinib filing
Gossamer Bio is trading 5.5% down now at $10.33 as investors reassess the September 23, 2026 FDA submission for seralutinib. - The application follows PROSERA...
🟢 Gossamer Bio is trading 5.6% up today after filing its first FDA New Drug Application
Gossamer Bio is trading at $11.61, up 5.60% after submitting its first FDA New Drug Application for seralutinib on September 23. - The application targets...
Gossamer Bio Submits First New Drug Application to FDA for Seralutinib
Gossamer Bio announced it has submitted its first New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its drug candidate,...
🔴 Gossamer Bio is trading 10.35% down today as rising oil prices renew inflation concerns
Gossamer Bio is trading 10.35% down at $10.48 on September 23, 2026, as rising crude prices renew inflation concerns and weigh on equity valuations. - U.S....
🔴 Gossamer Bio is trading 5.8% down today with no clear catalyst identified
Gossamer Bio is trading 5.8% down now at $11.01, and the cause remains unclear. - No clear company-specific announcement or catalyst dated September 23, 2026...
🟢 Gossamer Bio is trading 5.4% up today after H.C. Wainwright raised its target to $90
Gossamer Bio is trading 5.4% up at $11.89 after continued investor reaction to H.C. Wainwright maintaining a Buy rating and raising its price target from $2 to...
🟢 Gossamer Bio is trading 9.23% up today as U.S. markets open higher
Gossamer Bio is trading 9.23% up at $11.72 as U.S. markets open higher. - The S&P 500 is up 0.65%. - The Nasdaq Composite is up 0.85%. - No company-specific...
🟢 Gossamer Bio is trading 12.21% up in pre-market as major U.S. indices gain over 0.5%
Gossamer Bio is trading 12.21% up at $12.04 as broader risk-on sentiment lifts major U.S. indices. - The S&P 500, Nasdaq Composite, and Dow Jones were all...
🟢 Gossamer Bio is trading 5.4% up in pre-market amid broader risk-on sentiment
Gossamer Bio is trading 5.41% up at $11.31 amid broader risk-on sentiment; no new company-specific announcement was identified for September 21, 2026. - The...
🟢 Gossamer Bio is trading 7.27% up today in after-hours trading despite no new company-specific announcement
Gossamer Bio is trading 7.27% up in after-hours trading at $11.51 after closing September 18, 2026, at $10.73, with no new company-specific announcement dated...
🔴 Gossamer Bio is trading 9.4% down today after recent rally
Gossamer Bio is trading at $10.81 (-9.42%), likely reflecting profit-taking after its recent rally. • Shares gained 8.94% on September 17 and 5.59% on...
🟢 Gossamer Bio is trading 10.04% up today amid biotech-sector strength
Gossamer Bio is trading at $12.06, up 10.04%, as biotech stocks rally. - The biotech sector is up 2.55%, alongside stronger major indexes. - No clear...
🟢 Gossamer Bio is trading 8.6% up today as biotech stocks rally
Gossamer Bio is trading at $11.72, up 8.57%, as biotech-sector strength and a broader risk-on market rebound support the move. - No fresh company-specific...
🟢 Gossamer Bio is trading 7% up today with no clear company-specific catalyst identified
Gossamer Bio is trading 6.89% up at $11.10, with no clearly reported company-specific catalyst identified for September 16, 2026. - The 1-for-80 reverse stock...